Leukocare and Sanofi Pasteur sign cooperation agreement for vaccine stabilization
Advertisement
Leukocare AG announced the signing of a cooperation agreement with Sanofi Pasteur, the vaccines division of Sanofi. As part of this cooperation, Sanofi Pasteur will explore Leukocare ’s SPS platform technology to enhance the shelf-life of selected vaccine formulations.
Leukocare’s Stabilizing and Protecting Solutions (SPS) are employed in the biopharmaceutical, medical device and diagnostics industries to enhance the shelf-life of proteins and to enable terminal sterilization by irradiation or Ethylene Oxide. Terminal sterilization allows for a significant reduction in production costs by avoiding complex aseptic production and at the same time, improves product safety, as most sources of error can be excluded in one single step.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Sanofi to acquire Bioverativ for $11.6 billion
Eckert & Ziegler: new production location in Warsaw being planned - Eckert & Ziegler to become the long-term contrast agent supplier to leading Polish clinic chain
Chocolate’s tasty flavors might pose a risk in other desserts - Genotoxic substances in baked sweets?
ResMed Acquires Laboratoires Narval - Expands Current Therapy Range and Patient Reach through Acquisition
Aҫaí berry extracts fight malaria in mice
Fraunhofer IPA transfers rights to use laboratory robot KEVIN United Robotics Group - KEVIN can be flexibly and intuitively integrated into laboratory infrastructures and automates processes
Combined HIV and hepatitis C virus vaccination a possibility
Unlocking the secrets of bat immunity - Organoids unveil new defense mechanisms against zoonotic viruses
Development of an Efficient Enantioselective Desymmetrization Strategy Using Recombinant Pig Liver Esterases
Mapping human brain development - With the help of brain organoids, ETH researchers are investigating gene networks that control the development of different brain regions
Sanofi delivered 2015 business EPS up 8.5%